Clinical acceptance and accuracy assessment of spinal implants guided with SpineAssist surgical robot: retrospective study.
02 2011, Spine
Authors: Devito DP, Kaplan L, Dietl R, Pfeiffer M, Horne D, Silberstein B, Hardenbrook M, Kiriyanthan G, Barzilay Y, Bruskin A, Sackerer D, Alexandrovsky V, Stüer C, Burger R, Maeurer J, Donald GD, Gordon DG, Schoenmayr R, Friedlander A, Knoller N, Schmieder K, Pechlivanis I, Kim IS, Meyer B, Shoham M
Robotic assisted spinal surgery--from concept to clinical practice.
09 2007, Computer aided surgery : official journal of the International Society for Computer Aided Surgery
Authors: Shoham M, Lieberman IH, Benzel EC, Togawa D, Zehavi E, Zilberstein B, Roffman M, Bruskin A, Fridlander A, Joskowicz L, Brink-Danan S, Knoller N
In vivo evaluation of cysteine-based chelators for attachment of 99mTc to tumor-targeting Affibody molecules.
05 2007, Bioconjugate chemistry
Authors: Tran T, Engfeldt T, Orlova A, Widström C, Bruskin A, Tolmachev V, Karlström AE
Imaging of HER2-expressing tumours using a synthetic Affibody molecule containing the 99mTc-chelating mercaptoacetyl-glycyl-glycyl-glycyl (MAG3) sequence.
09 2007, European journal of nuclear medicine and molecular imaging
Authors: Engfeldt T, Orlova A, Tran T, Bruskin A, Widström C, Karlström AE, Tolmachev V
Radio-iodination of monoclonal antibody using potassium [125I]-(4-isothiocyanatobenzylammonio)-iodo-decahydro-closo-dodecaborate (iodo-DABI).
05 2006, Anticancer research
Authors: Orlova A, Bruskin A, Sivaev I, Sjöberg S, Lundqvist H, Tolmachev V
Comparative biodistribution of potential anti-glioblastoma conjugates [111In]DTPA-hEGF and [111In]Bz-DTPA-hEGF in normal mice.
03 2005, Cancer biotherapy & radiopharmaceuticals
Authors: Tolmachev V, Orlova A, Wei Q, Bruskin A, Carlsson J, Gedda L
[177Lu]Bz-DTPA-EGF: Preclinical characterization of a potential radionuclide targeting agent against glioma.
12 2004, Cancer biotherapy & radiopharmaceuticals
Authors: Sundberg AL, Gedda L, Orlova A, Bruskin A, Blomquist E, Carlsson J, Tolmachev V
Radiobromination of monoclonal antibody using potassium [76Br] (4 isothiocyanatobenzyl-ammonio)-bromo-decahydro-closo-dodecaborate (Bromo-DABI).
11 2004, Nuclear medicine and biology
Authors: Bruskin A, Sivaev I, Persson M, Lundqvist H, Carlsson J, Sjöberg S, Tolmachev V
[(111)In]Bz-DTPA-hEGF: Preparation and in vitro characterization of a potential anti-glioblastoma targeting agent.
05 2004, Cancer biotherapy & radiopharmaceuticals
Authors: Sundberg AL, Orlova A, Bruskin A, Gedda L, Carlsson J, Blomquist E, Lundqvist H, Tolmachev V
110mIn-DTPA-D-Phe1-octreotide for imaging of neuroendocrine tumors with PET.
10 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Authors: Lubberink M, Tolmachev V, Widström C, Bruskin A, Lundqvist H, Westlin JE
Intra-synovial, compared to intra-articular morphine provides better pain relief following knee arthroscopy menisectomy.
08 2002, Canadian journal of anaesthesia = Journal canadien d'anesthésie
Authors: Kligman M, Bruskin A, Sckliamser J, Vered R, Roffman M
Cellular processing of (125)I- and (111)in-labeled epidermal growth factor (EGF) bound to cultured A431 tumor cells.
03 2001, Nuclear medicine and biology
Authors: Orlova A, Bruskin A, Sjöström A, Lundqvist H, Gedda L, Tolmachev V
Transforming growth factor-B3 protects murine small intestinal crypt stem cells and animal survival after irradiation, possibly by reducing stem-cell cycling.
04 2000, International journal of cancer. Journal international du cancer
Authors: Booth D, Haley JD, Bruskin AM, Potten CS
Oral mucosal permeability and stability of transforming growth factor beta-3 in vitro.
12 1999, Pharmaceutical research
Authors: Squier CA, Kremer MJ, Bruskin A, Rose A, Haley JD
Positron emission tomography and radioimmunotargeting--general aspects.
07 1999, Acta oncologica (Stockholm, Sweden)
Authors: Lundqvist H, Lubberink M, Tolmachev V, Lövqvist A, Sundin A, Beshara S, Bruskin A, Carlsson J, Westlin JE
Identification and characterization of baxepsilon, a novel bax variant missing the BH2 and the transmembrane domains.
03 1999, Biochemical and biophysical research communications
Authors: Shi B, Triebe D, Kajiji S, Iwata KK, Bruskin A, Mahajna J
A p53 growth arrest protects fibroblasts from anticancer agents.
03 2006, Frontiers in bioscience : a journal and virtual library
Authors: McCormack ES, Bruskin AM, Borzillo GV
A four-amino-acid insertion in the ligand-binding domain inactivates hRXRbeta and renders dominant negative activity.
06 1997, DNA and cell biology
Authors: Mahajna J, Shi B, Bruskin A
Transforming growth factor-beta 3 mediated modulation of cell cycling and attenuation of 5-fluorouracil induced oral mucositis.
06 1997, Oral oncology
Authors: Sonis ST, Van Vugt AG, Brien JP, Muska AD, Bruskin AM, Rose A, Haley JD
Depletion of the erbB-2 gene product p185 by benzoquinoid ansamycins.
06 1994, Cancer research
Authors: Miller P, DiOrio C, Moyer M, Schnur RC, Bruskin A, Cullen W, Moyer JD
Isolation and mapping of human T-cell protein tyrosine phosphatase sequences: localization of genes and pseudogenes discriminated using fluorescence hybridization with genomic versus cDNA probes.
08 1993, Genomics
Authors: Johnson CV, Cool DE, Glaccum MB, Green N, Fischer EH, Bruskin A, Hill DE, Lawrence JB
[Percutaneous trephine for vertebral biopsy].
08 1993, Harefuah
Authors: Waisman M, Roffman M, Bruskin A
Effect of protein tyrosine phosphatase 1B expression on transformation by the human neu oncogene.
02 1992, Cancer research
Authors: Brown-Shimer S, Johnson KA, Hill DE, Bruskin AM
Requirements for the internalization of a murine monoclonal antibody directed against the HER-2/neu gene product c-erbB-2.
10 1991, Cancer research
Authors: Maier LA, Xu FJ, Hester S, Boyer CM, McKenzie S, Bruskin AM, Argon Y, Bast RC
Identification of p53 as a sequence-specific DNA-binding protein.
07 1991, Science (New York, N.Y.)
Authors: Kern SE, Kinzler KW, Bruskin A, Jarosz D, Friedman P, Prives C, Vogelstein B
Transformation of early erythroid precursor cells (BFU-E) by a recombinant murine retrovirus containing v-erb-B.
10 1990, Oncogene
Authors: Miller M, Kennewell A, Takayama Y, Bruskin A, Bishop JM, Johnson G, Symonds G
Molecular cloning and chromosome mapping of the human gene encoding protein phosphotyrosyl phosphatase 1B.
08 1990, Proceedings of the National Academy of Sciences of the United States of America
Authors: Brown-Shimer S, Johnson KA, Lawrence JB, Johnson C, Bruskin A, Green NR, Hill DE
Six amino acids from the retroviral gene gag greatly enhance the transforming potential of the oncogene v-erb-B.
05 1990, Oncogene
Authors: Bruskin A, Jackson J, Bishop JM, McCarley DJ, Schatzman RC
Transformation of murine myelomonocytic cells by myc: point mutations in v-myc contribute synergistically to transforming potential.
05 1989, Oncogene
Authors: Symonds G, Hartshorn A, Kennewell A, O'Mara MA, Bruskin A, Bishop JM
Отзывы
